Genome-Wide Gene–Diabetes and Gene–Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia
Hongwei Tang(First Affiliated Hospital of Zhengzhou University), Nathaniel Rothman, Charles Kooperberg(Fred Hutch Cancer Center), Federico Canzian(German Cancer Research Center), Robert N. Hoover(Tulane University), J. Michael Gaziano(VA Boston Healthcare System), Amanda L. Blackford(Johns Hopkins University), Steven Gallinger(Ontario Institute for Cancer Research), Graham G. Giles(The University of Melbourne), Alan A. Arslan(New York University), Demetrius Albanes(National Cancer Institute), Ana Babić(Dana-Farber Brigham Cancer Center), Manal H. Hassam(The University of Texas MD Anderson Cancer Center), William R. Bamlet(Mayo Clinic), Núria Malats(Spanish National Cancer Research Centre), Roger L. Milne(The University of Melbourne), Charles S. Fuchs(University of Southern California), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Paige M. Bracci(University of California, San Francisco), I-Min Lee(Brigham and Women's Hospital), Ulrike Peters(University of Washington), Rayjean J. Hung, Miquel Porta(University of North Carolina at Chapel Hill), Sonja I. Berndt(Department of Health and Human Services), Irene Orlow(Memorial Sloan Kettering Cancer Center), Ann L. Oberg(University of Minnesota), Daniele Campa(University of Pisa), Mengmeng Du(Memorial Sloan Kettering Cancer Center), Eric J. Duell(Dartmouth College), Rachael Z. Stolzenberg‐Solomon(National Cancer Institute), Emily White(Michigan State University), Kimmie Ng(Dana-Farber Cancer Institute), Rachel Ε. Neale(The University of Queensland), Erica J. Childs(Johns Hopkins University), Kari G. Rabe(Mayo Clinic), Xiao‐Ou Shu(Vanderbilt University Medical Center), Laura E. Beane Freeman(National Cancer Institute), Gabriella Andreotti, Bas Bueno‐de‐Mesquita(University Medical Center Utrecht), Robert C. Kurtz(Memorial Sloan Kettering Cancer Center), Kala Visvanathan(Johns Hopkins University), Michael Goggins(Johns Hopkins University), Julie E. Buring(Brigham and Women's Hospital), Stephen J. Chanock(National Cancer Institute), Wei Zheng(Vanderbilt University), Elizabeth A. Holly(University of California, San Francisco), Lai Jiang(University of North Carolina at Chapel Hill), Paul Brennan(Centre international de recherche sur le cancer), Patricia Hartge(National Institutes of Health), Phyllis J. Goodman(Translational Research Institute)
Cited by 10
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k